Plus Therapeutics Inc (NASDAQ: PSTV) kicked off on Monday, up 28.16% from the previous trading day, before settling in for the closing price of $0.29. Over the past 52 weeks, PSTV has traded in a range of $0.24-$2.67.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -3.61% over the last five years. While this was happening, its average annual earnings per share was recorded 57.69%. With a float of $15.49 million, this company’s outstanding shares have now reached $17.00 million.
The firm has a total of 21 workers. Let’s measure their productivity. In terms of profitability, gross margin is -0.1%, operating margin of -497.12%, and the pretax margin is -439.04%.
Plus Therapeutics Inc (PSTV) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Plus Therapeutics Inc is 8.87%, while institutional ownership is 9.41%. The most recent insider transaction that took place on May 15 ’25, was worth 20,276. Before that another transaction happened on Sep 13 ’24, when Company’s Director bought 4,000 for $1.50, making the entire transaction worth $5,996. This insider now owns 15,188 shares in total.
Plus Therapeutics Inc (PSTV) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 57.69% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 49.89% during the next five years compared to 46.51% growth over the previous five years of trading.
Plus Therapeutics Inc (NASDAQ: PSTV) Trading Performance Indicators
Take a look at Plus Therapeutics Inc’s (PSTV) current performance indicators. Last quarter, stock had a quick ratio of 0.99. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.20.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.50, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.76 in one year’s time.
Technical Analysis of Plus Therapeutics Inc (PSTV)
Analysing the last 5-days average volume posted by the [Plus Therapeutics Inc, PSTV], we can find that recorded value of 38.22 million was better than the volume posted last year of 12.53 million. As of the previous 9 days, the stock’s Stochastic %D was 19.51%. Additionally, its Average True Range was 0.11.
During the past 100 days, Plus Therapeutics Inc’s (PSTV) raw stochastic average was set at 6.17%, which indicates a significant decrease from 22.17% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 203.41% in the past 14 days, which was lower than the 351.81% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7098, while its 200-day Moving Average is $1.1226. Now, the first resistance to watch is $0.5825. This is followed by the second major resistance level at $0.7972. The third major resistance level sits at $0.9335. If the price goes on to break the first support level at $0.2315, it is likely to go to the next support level at $0.0952.
Plus Therapeutics Inc (NASDAQ: PSTV) Key Stats
The company with the Market Capitalisation of 6.25 million has total of 17,000K Shares Outstanding. Its annual sales at the moment are 5,820 K in contrast with the sum of -12,980 K annual income. Company’s last quarter sales were recorded 1,410 K and last quarter income was -3,900 K.
